Anagenics Ltd has released a press release.
Cellmid to commence selling of evolis into chinese market
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid secures bloomingdales usa partnership for evolis
- Appendix 4C - quarterly
- Cellmid signs distribution agreement for fillerina
- Appendix 4D and Half Year Accounts
- Record 2M sales for cellmid FGF5 inhibitors
Later from Anagenics
- Cellmid updates on distribution of evolis
- Cellmid Share Placement Raises $9M
- Cellmid Share Purchase Plan
- Cleansing Notice and Appendix 3B
- Preliminary Final Report
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics